HomeCompareTGRNF vs PLD

TGRNF vs PLD: Dividend Comparison 2026

TGRNF yields 4.55% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.88M in total portfolio value
10 years
TGRNF
TGRNF
● Live price
4.55%
Share price
$0.55
Annual div
$0.03
5Y div CAGR
9.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.5K
Annual income
$1,748.22
Full TGRNF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — TGRNF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTGRNFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TGRNF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TGRNF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TGRNF
Annual income on $10K today (after 15% tax)
$386.94/yr
After 10yr DRIP, annual income (after tax)
$1,485.99/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,036,630.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TGRNF + PLD for your $10,000?

TGRNF: 50%PLD: 50%
100% PLD50/50100% TGRNF
Portfolio after 10yr
$2.97M
Annual income
$2,376,236.70/yr
Blended yield
80.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

TGRNF
No analyst data
Altman Z
3.0
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TGRNF buys
0
PLD buys
0
No recent congressional trades found for TGRNF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTGRNFPLD
Forward yield4.55%3.10%
Annual dividend / share$0.03$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.4%74.4%
Portfolio after 10y$32.5K$5.91M
Annual income after 10y$1,748.22$4,750,725.19
Total dividends collected$10.0K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TGRNF vs PLD ($10,000, DRIP)

YearTGRNF PortfolioTGRNF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$11,198$498.01$11,241$540.96$43.00PLD
2$12,552$570.18$13,019$991.13$467.00PLD
3$14,084$653.46$15,801$1,870.97$1.7KPLD
4$15,820$749.67$20,609$3,701.21$4.8KPLD
5$17,788$860.93$29,919$7,867.97$12.1KPLD
6$20,023$989.77$50,631$18,617.74$30.6KPLD
7$22,564$1,139.11$105,528$51,352.20$83.0KPLD
8$25,456$1,312.45$287,364$174,449.42$261.9KPLD
9$28,751$1,513.87$1,081,760$774,280.77$1.05MPLD
10$32,512$1,748.22$5,908,209$4,750,725.19$5.88MPLD

TGRNF vs PLD: Complete Analysis 2026

TGRNFStock

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Full TGRNF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this TGRNF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TGRNF vs SCHDTGRNF vs JEPITGRNF vs OTGRNF vs KOTGRNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.